Pharmaceutical composition for specifically regulating activity of hypothalamic ventral nucleus astrocyte and application of pharmaceutical composition
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
- Publication Date
- 2021-10-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine, and specifically relates to a pharmaceutical composition for specifically regulating the activity of astrocytes in the ventromedial nucleus of the hypothalamus and an application thereof. Background technique
[0002] Research evidence shows that nervous system function and bone metabolism are interrelated. Combined with a large amount of experimental data, some researchers have proposed that all organs maintain the overall physiological function balance through organ talk; bone growth, metabolism and remodeling are regulated by multiple organs in the body, and bone metabolism itself also affects It affects the function of several vital organs including the brain, gonads and digestive system.
[0003] In addition, a large number of research data show that anxiety and depression are closely related to bone loss, but the underlying mechanism is still unclear. And through case correlation anal...